Meditoxin (exported as Neuronox) is Medytox’s original complex-type botulinum toxin type A: a freeze-dried 200 U vial with human serum albumin and sodium chloride, reconstituted with preservative-free saline before injection, and registered with Korea’s MFDS. Medytox has no FDA-approved toxin, so no FDA status is claimed. Potency units are product-specific. Professional use only.
What is Meditoxin?
Meditoxin is Medytox’s original botulinum toxin type A (exported as Neuronox), one of the first Korean toxins to reach wide use. It is a complex-type freeze-dried preparation stabilised with human serum albumin and sodium chloride, supplied here as a 200 U single-use vial and reconstituted with preservative-free saline before injection. Potency units are specific to this product and are not interchangeable with other botulinum toxin products.
How does Meditoxin compare with other Medytox toxins?
Medytox makes several toxins. Meditoxin is the complex-type original; Coretox is positioned free of complexing proteins; and Innotox is the ready-to-use liquid. The 200 U vial suits higher-volume caseloads.
| Meditoxin | Medytox · complex-type · freeze-dried · 200 U |
|---|---|
| Coretox | Medytox · free of complexing proteins · 100 U |
| Innotox | Medytox · ready-to-use liquid · 50/100 U |
What do clinics use Meditoxin for?
Clinics select Meditoxin for facial expression-line work and other aesthetic indications decided by the treating professional. Dosing and technique are product-specific and follow the manufacturer’s labelling; units are not interchangeable with other toxins.
Commonly selected for
- Clinics standardised on Medytox units
- Higher-volume 200 U caseloads
- Established complex-type toxin protocols
- Aesthetic expression-line work
How is Meditoxin supplied?
One 200 U single-use vial. Supplied as a lyophilised (freeze-dried) preparation; reconstitute with preservative-free 0.9% sodium chloride before use. Reconstitute immediately before use and follow the manufacturer’s handling instructions.
Reviewed against publicly available manufacturer information. Indications, dosing and technique are product-specific per the manufacturer’s labeling and are decided by the treating clinician.
Specifications
| Brand | Meditoxin (Medytox) |
|---|---|
| Manufacturer | Medytox Inc. (South Korea) |
| Origin | South Korea |
| Active | Botulinum toxin type A (200 U) |
| Composition | Clostridium botulinum type A toxin, complex type; with human serum albumin and sodium chloride; contains complexing proteins |
| Units | 200 U |
| Format | 200 U single-use vial |
| Areas | Facial expression lines (aesthetic use) |
| Delivery | Reconstitute with preservative-free 0.9% saline; inject intramuscularly per the practitioner’s protocol |
| Regulatory | Registered with Korea’s MFDS (exported as Neuronox). Its maker, Medytox, does not have an FDA-approved botulinum toxin product, so no FDA status is claimed. |
| Administration | Injectable — by a qualified medical professional only |
| Storage & handling | Store refrigerated (2–8 °C) per the manufacturer’s instructions. |
Frequently asked questions
What is Meditoxin?
Medytox’s original botulinum toxin type A, exported under the name Neuronox, supplied as a freeze-dried 200 U vial.
Is Meditoxin FDA-approved?
No. It is registered with Korea’s MFDS. Medytox does not have an FDA-approved botulinum toxin product.
Does it contain complexing proteins?
Yes. Meditoxin is a complex-type toxin and contains the accessory complexing proteins, with human serum albumin and sodium chloride.
How is it supplied?
As one freeze-dried 200 U single-use vial, reconstituted with preservative-free 0.9% saline before use.
Are its units interchangeable with other toxins?
No. Potency units are specific to this product and are not converted 1:1 to other botulinum toxin products.